Drs Kaleb Abbott, Andrew Pucker suggest changing "artificial tear" terminology | Optometry Times - Clinical News

Published on December 10, 2025
The eye care providers authored an opinion article that has been published in "The Ocular Surface."
Continue reading on website
Other news

Tirzepatide Associated with Lower POAG, OHT Risk Compared with Other GLP-1 Drugs

December 10, 2025
Thus, the comparable tolerability of tirzepatide, despite its dual receptor activity, supports its feasibility for long-term use – an important consideration in managing chronic conditions like glaucoma. Photo: Eli Lilly. Click image to enlarge. Tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 receptor agonist (GLP-1 RA), has

EssilorLuxottica seeks to accelerate innovation

December 10, 2025
The company has established a Scientific Advisory Committee to support its innovation ambitions